Xenetic Biosciences, Inc. Quarterly Common Stock, Shares, Issued from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Xenetic Biosciences, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2011 to Q3 2024.
  • Xenetic Biosciences, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 1.54M shares, a 0.62% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.54M +9.54K +0.62% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.54M +8.5K +0.55% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 1.54M -13.7M -89.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 1.54M +24K +1.58% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 1.54M -12.8M -89.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.54M -12.8M -89.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 15.2M +1.73M +12.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.52M -11.9M -88.7% Dec 31, 2022 10-K 2024-03-21
Q3 2022 14.3M +931K +6.94% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 14.3M +5.57M +63.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 13.5M +4.69M +53.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 13.5M +4.69M +53.5% Dec 31, 2021 10-K 2023-03-22
Q3 2021 13.4M +7.09M +112% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 8.77M +2.45M +38.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 8.77M +2.46M +39% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 8.77M +2.68M +44% Dec 31, 2020 10-K 2022-03-22
Q3 2020 6.32M +663K +11.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 6.32M +5.37M +566% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 6.31M -4.46M -41.4% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 6.09M +5.28M +651% Dec 31, 2019 10-K 2021-03-16
Q3 2019 5.66M -4.07M -41.8% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 949K -8.78M -90.2% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 10.8M +1.73M +19.1% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 811K -8.23M -91% Dec 31, 2018 10-K 2020-03-26
Q3 2018 9.73M +686K +7.59% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 9.73M +686K +7.59% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 9.04M +65K +0.72% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 9.04M +4.13M +84.2% Dec 31, 2017 10-K 2019-03-29
Q3 2017 9.04M +429K +4.98% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 9.04M -307K -3.29% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 8.98M -154M -94.5% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 4.91M 0 0% Dec 31, 2016 10-K 2018-03-30
Q3 2016 8.61M -142M -94.3% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 9.35M -141M -93.8% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 163M +12.7M +8.47% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 4.91M -145M -96.7% Dec 31, 2015 10-K 2017-03-31
Q3 2015 151M +3.77M +2.57% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 150M +3.24M +2.21% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 150M +3.24M +2.21% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 150M +19.4M +14.9% Dec 31, 2014 10-K 2016-03-30
Q3 2014 147M +11.7M +8.7% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 147M +11.7M +8.7% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 147M +133M +987% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 131M +55.4K +0.04% Dec 31, 2013 10-K/A 2015-07-20
Q3 2013 135M 0 0% Aug 31, 2013 10-Q 2014-01-10
Q2 2013 135M +122M +900% May 31, 2013 10-Q 2013-07-17
Q1 2013 13.5M -21.5M -61.4% Feb 28, 2013 10-Q 2013-04-22
Q4 2012 131M Dec 31, 2012 10-K/A 2015-07-20
Q3 2012 135M +125M +1250% Aug 31, 2012 10-K 2013-11-27
Q2 2012 13.5M May 31, 2012 10-Q 2012-07-16
Q1 2012 35M Apr 6, 2012 10-K 2013-11-27
Q3 2011 10M Aug 31, 2011 10-K 2012-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.